13F HOLDINGS REPORT
Fairmount Funds Management LLC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001104659-24-118833
Total Value
$1.23B
Positions
15
Other Managers
0
Confidential Omitted
No
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AXSOME THERAPEUTICS INC | AXSM | 2,360,077 | $212.1M | 17.20% |
| 2 | NUVALENT INC | NUVL | 1,687,064 | $172.6M | 13.99% |
| 3 | APOGEE THERAPEUTICS INC | APGE | 2,048,647 | $120.3M | 9.76% |
| 4 | SPYRE THERAPEUTICS INC | SYRE | 4,018,101 | $118.2M | 9.58% |
| 5 | ENLIVEN THERAPEUTICS INC | ELVN | 3,202,798 | $81.8M | 6.63% |
| 6 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 3,204,841 | $80.1M | 6.49% |
| 7 | ORUKA THERAPEUTICS INC | ORKA | 3,211,922 | $78.7M | 6.38% |
| 8 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,445,813 | $78.4M | 6.36% |
| 9 | DIANTHUS THERAPEUTICS INC | DNTH | 2,700,691 | $73.9M | 6.00% |
| 10 | COGENT BIOSCIENCES INC | COGT | 6,225,641 | $67.2M | 5.45% |
| 11 | DAY ONE BIOPHARMACEUTICALS INC | DAWN | 3,103,448 | $43.2M | 3.51% |
| 12 | ASTRIA THERAPEUTICS INC | 04635X102 | 3,554,129 | $39.1M | 3.17% |
| 13 | BICARA THERAPEUTICS INC | BCAX | 1,284,169 | $32.7M | 2.65% |
| 14 | ZENAS BIOPHARMA INC | ZBIO | 1,892,806 | $32.0M | 2.60% |
| 15 | BICYCLE THERAPEUTICS PLC | BCYC | 123,538 | $2.8M | 0.23% |